Raven, Breast Reduction

The company found that the 1 mg dose of Z-endoxifen reduced MBD by 17.3 percentage points, whereas the 2 mg dose achieved a reduction of 23.5 percentage points. Meanwhile, a minimal change of 0.27 ...
Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free ...
Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...
Reduction in distant recurrence consistently deepened beyond 3-year Kisqali treatment duration in patients with node-positive (N+) and high-risk node-negative (N0) disease, as well as between ...